跳至主要内容
临床试验/CTRI/2024/02/062918
CTRI/2024/02/062918尚未招募不适用

Immunohistochemical expression of Bcl-2 and Ki-67 in non-neoplastic and neoplastic endometrial lesions- A cross sectional study

Pragya chitravanshi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年2月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To classify non neoplastic and neoplastic endometrial lesions on the basis of histomorphology.

研究概览

简要总结

The study will be conducted in the Department of Pathology Rohilkhand Medical

College and Hospital, Bareilly after taking approval from Institutional Ethics

Committee, and consent from the patient and will include all endometrial biopsies and

hysterectomy specimens in the department during the study period.

The received specimens will be subjected to gross and microscopic examination as per

standard protocol.

Paraffin embedded tissues (4-5 microns) will be cut and stained by Haematoxylin and

Eosin stain.

Immunohistochemistry will be carried out using Bcl-2 and Ki-67 as primary antibodies

and High Reactive Polymer as a secondary kit.

Microwave antigen retrieval will be carried out in pH 9 TrisEDTA buffer. Using DAB

as the chromogen, staining.

Observations will be made on Immunohistochemistry stained slides and documented.

Prepared slides will be viewed under an optical microscope x400 magnification, for

positive or negative immunostaining.

Biopsies which shows positive for Bcl-2 and Ki-67 expressions will be included.

Calculations will be made regarding staining percentage and intensity.

The positive number of cells for Bcl-2 expressions will count in 100 epithelial cells and

repeated in 10 HPFs. [7]

Positive epithelial cells will be graded on the basis of intensity. [7]

910

o Grade 0 – Absent

o Grade 1 –Mild

o Grade 2 – Moderate

o Grade 3 – Strong

o Grade 4 – Very strong

Positive control: Placental tissue will be used as a positive control for Bcl-2 whose

staining is always grade 4.[7]

The positive number of cells for Ki-67 expressions will count in 100 epithelial cells and

repeated in 10 HPFs and then positive cells for Ki-67 expressions will be calculated

using the percentage of 1000. these cells will be graded on the basis of their positivity

as follows.[7]

o <5% - Grade 0

o 6-25% - Grade 1

o 26-50% - Grade 2

o 51- 75% - Grade 3

o 76-100% - Grade 4

Positive control: Tonsil will be taken as a control for Ki-67 expression

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
Female

入选标准

  • All histopathologically confirmed cases of non neoplastic and neoplastic endometrial lesions.

排除标准

  • Patients who are on hormonal therapy Biopsies diagnosed as the product of conception Biopsies that are unsatisfactory.

结局指标

主要结局

To classify non neoplastic and neoplastic endometrial lesions on the basis of histomorphology.

时间窗: Monthly

To evaluate Bcl-2 and Ki-67 expression in non-neoplastic and neoplastic endometrial lesions.

时间窗: Monthly

To correlate Bcl-2 with Ki-67 expression in these lesions

时间窗: Monthly

次要结局

  • To classify non neoplastic & neoplastic endometrial lesions on the basis of histomorphology.

研究者

发起方
Pragya chitravanshi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Pragya chitravanshi

Rohilkhand Medical College and Hospital

研究点 (1)

Loading locations...

相似试验

Role of Bcl-2 and Ki67 in endometrial lesions | 临床试验